Clinical Drug Experience Knowledgebase

amlodipine (norvasc) (5 trials)

amoxicillin (1 trial)

Andrographis paniculata (4 trials)

artesunate (1 trial)

avatrombopag (1 trial)

azithromycin (zithromax) (1 trial)

baclofen (lioresal) (1 trial)

bifidobacterium animalis (1 trial)

bismuth (1 trial)

cephalexin (keflex) (1 trial)

ciprofloxacin (cipro) (1 trial)

cisatracurium (nimbex) (2 trials)

cisplatin (platinol) (4 trials)

clavulanate (Augmentin) (1 trial)

danoprevir (1 trial)

dexmedetomidine (precedex) (1 trial)

docetaxel (taxotere) (1 trial)

doxycycline (vibramycin) (1 trial)

eltrombopag (promacta) (1 trial)

enalapril (vasotec) (2 trials)

entecavir (baraclude) (3 trials)

esomeprazole (nexium) (1 trial)

fluorouracil (efudex) (1 trial)

folic acid (4 trials)

fruquintinib (Fruzaqla) (2 trials)

fuganlin (1 trial)

furazolidone (furoxone) (1 trial)

fuzhenghuayu (2 trials)

hyaluronic acid (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

interferon alpha-2b (Intron-A) (6 trials)

ixazomib (ninlaro) (1 trial)

Lactobacillus acidophilus (1 trial)

lenalidomide (revlimid) (2 trials)

lopinavir (Kaletra) (1 trial)

metoclopramide (reglan) (1 trial)

minocycline (minocin) (2 trials)

nifekalant (1 trial)

oseltamivir (tamiflu) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

propofol (diprivan) (5 trials)

reduning (1 trial)

remifentanil (ultiva) (2 trials)

remimazolam (Byfavo) (5 trials)

ritonavir (Norvir) (1 trial)

sevoflurane (ultane) (2 trials)

sufentanil (1 trial)

thrombopoietin (1 trial)

vonoprazan (Voquezna) (1 trial)

xiaoer jiebiao (1 trial)

alteplase (Activase) (2 trials)

cladribine (leustatin) (1 trial)

cyclophosphamide (cytoxan) (3 trials)

cytarabine (cytosar-u) (1 trial)

doxorubicin (Doxil) (2 trials)

Filgrastim (neupogen) (1 trial)

gemcitabine (gemzar) (2 trials)

idarubicin (idamycin) (1 trial)

irbesartan (avapro) (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

methotrexate (1 trial)

methylprednisolone (medrol) (2 trials)

mitoxantrone (novantrone) (1 trial)

mycophenolate (CellCept) (1 trial)

polyethylene glycol (2 trials)

potassium sulfate (1 trial)

prednisone (meticorten) (5 trials)

rituximab (rituxan) (1 trial)

sodium sulfate (1 trial)

sorafenib (nexavar) (1 trial)

tamoxifen (nolvadex) (1 trial)

thalidomide (Thalomid) (1 trial)

toremifene (fareston) (1 trial)

vincristine (oncovin) (2 trials)

zanubrutinib (Brukinsa) (1 trial)

ak104 (1 trial)

anlotinib (5 trials)

aripiprazole (abilify) (1 trial)

bat4406f (1 trial)

bevacizumab (avastin) (5 trials)

bn104 (1 trial)

bortezomib (velcade) (1 trial)

camrelizumab (1 trial)

capecitabine (xeloda) (1 trial)

cd19 car-t cells (3 trials)

cd30 car-t cell (1 trial)

cetuximab (erbitux) (1 trial)

cobalamin (1 trial)

crizotinib (xalkori) (1 trial)

dexamethasone (2 trials)

endostatin (endostar) (1 trial)

enoxaparin (lovenox) (1 trial)

erlotinib (tarceva) (1 trial)

fluvoxamine (luvox) (1 trial)

furmonertinib (Ives) (1 trial)

gefitinib (iressa) (3 trials)

gentamicin (garamycin) (1 trial)

icotinib (Conmana) (1 trial)

kl590586 (1 trial)

kn060 (1 trial)

lenvatinib (lenvima) (1 trial)

lidocaine (xylocaine) (1 trial)

lm-302 (1 trial)

memantine (namenda) (1 trial)

orelabrutinib (1 trial)

osimertinib (tagrisso) (2 trials)

pembrolizumab (keytruda) (1 trial)

pomalidomide (pomalyst) (1 trial)

recombinant bovine basic fibroblast growth factor (1 trial)

regorafenib (stivarga) (1 trial)

sertraline (zoloft) (1 trial)

sintilimab (1 trial)

temozolomide (temodar) (1 trial)

tislelizumab (3 trials)

toripalimab (LOQTORZ) (1 trial)

venlafaxine (effexor) (1 trial)

autologous cd19/cd22 chimeric antigen receptor t-cells (1 trial)

azacitidine (vidaza) (1 trial)

cd22 car-t cells (1 trial)

cd70 car-t cells (1 trial)

cea car-t cells (1 trial)

ciltacabtagene autoleucel (Carvykti) (1 trial)

cyclosporine (sandimmune) (1 trial)

epinephrine (levophed) (1 trial)

fludarabine (fludara) (1 trial)

human cd19 targeted dash car-t cells (1 trial)

loteprednol (lotemax) (1 trial)

lp-108 (1 trial)

mazdutide (1 trial)

mirabegron (myrbetriq) (1 trial)

neostigmine (bloxiverz) (1 trial)

recombinant influenza hemagglutinin (1 trial)

starch (1 trial)

tezepelumab (Tezspire) (1 trial)

tobramycin (nebcin) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

almonertinib (1 trial)

antigen pulsed dendritic cells (1 trial)

azathioprine (imuran) (1 trial)

basiliximab (Simulect) (1 trial)

dextrose (1 trial)

fentanyl (Innovar) (1 trial)

hou gu mi xi (3 trials)

leflunomide (arava) (1 trial)

linaclotide (linzess) (1 trial)

pemetrexed (alimta) (1 trial)

personalized neoantigen vaccine (1 trial)

progesterone (progestasert) (1 trial)

rabeprazole (pariet) (1 trial)

somatostatin (1 trial)

spironolactone (aldactone) (1 trial)

tacrolimus (prograf) (1 trial)

thymalfasin (zadaxin) (1 trial)

zhenqi buxue koufuye (1 trial)